Full text is available at the source.
Abstract
Nanoparticles may significantly improve cancer therapy by enhancing targeted drug delivery to tumor cells.
- Inefficient uptake by tumor cells is a major obstacle for nanoparticle-based therapies.
- Tumor cells must overcome multiple barriers, including vascular and stromal challenges, to uptake nanoparticles.
- Cell-penetrating peptides may enhance the penetration and escape of nanoparticles from endosomes.
- The physicochemical properties of nanoparticles could influence their uptake efficiency in tumor cells.
- Emerging strategies, such as biomimetic coatings and charge-reversal systems, aim to improve uptake and reduce toxicity to normal tissues.
- The review links various factors, including vascular transport and intracellular processes, as interdependent determinants of effective nanoparticle delivery.
Simplified